Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial
Condition(s):Dementia With Lewy BodiesLast Updated:December 21, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Dementia With Lewy BodiesLast Updated:December 21, 2023Recruiting
Condition(s):Irritable Bowel SyndromeLast Updated:August 22, 2023Completed
Condition(s):Diabetes Mellitus, Type 1Last Updated:October 6, 2021Completed
Condition(s):Hemodynamic Instability; Anesthesia, General; Anesthesia, IntravenousLast Updated:September 28, 2023Recruiting
Condition(s):Hemodynamic Instability; Anesthesia, General; Anesthesia, IntravenousLast Updated:March 21, 2022Completed
Condition(s):Hemodynamics Instability; Anesthesia, General; Anesthesia, IntravenousLast Updated:June 17, 2020Completed
Condition(s):Irritable Bowel SyndromeLast Updated:May 7, 2019Completed
Condition(s):Cold Agglutinin Disease; Autoimmune Hemolytic AnemiaLast Updated:January 9, 2017Completed
Condition(s):COPD; Coping; Quality of LifeLast Updated:January 10, 2024Completed
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:August 19, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.